Medial Temporal Lobe Subregional Atrophy in Aging and Alzheimer's Disease: A Longitudinal Study

Medial temporal lobe (MTL) atrophy is a key feature of Alzheimer's disease (AD), however, it also occurs in typical aging. To enhance the clinical utility of this biomarker, we need to better understand the differential effects of age and AD by encompassing the full AD-continuum from cognitivel...

Full description

Bibliographic Details
Main Authors: Léa Chauveau, Elizabeth Kuhn, Cassandre Palix, Francesca Felisatti, Valentin Ourry, Vincent de La Sayette, Gaël Chételat, Robin de Flores
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2021.750154/full
_version_ 1818585261907378176
author Léa Chauveau
Elizabeth Kuhn
Cassandre Palix
Francesca Felisatti
Valentin Ourry
Valentin Ourry
Vincent de La Sayette
Gaël Chételat
Robin de Flores
author_facet Léa Chauveau
Elizabeth Kuhn
Cassandre Palix
Francesca Felisatti
Valentin Ourry
Valentin Ourry
Vincent de La Sayette
Gaël Chételat
Robin de Flores
author_sort Léa Chauveau
collection DOAJ
description Medial temporal lobe (MTL) atrophy is a key feature of Alzheimer's disease (AD), however, it also occurs in typical aging. To enhance the clinical utility of this biomarker, we need to better understand the differential effects of age and AD by encompassing the full AD-continuum from cognitively unimpaired (CU) to dementia, including all MTL subregions with up-to-date approaches and using longitudinal designs to assess atrophy more sensitively. Age-related trajectories were estimated using the best-fitted polynomials in 209 CU adults (aged 19–85). Changes related to AD were investigated among amyloid-negative (Aβ−) (n = 46) and amyloid-positive (Aβ+) (n = 14) CU, Aβ+ patients with mild cognitive impairment (MCI) (n = 33) and AD (n = 31). Nineteen MCI-to-AD converters were also compared with 34 non-converters. Relationships with cognitive functioning were evaluated in 63 Aβ+ MCI and AD patients. All participants were followed up to 47 months. MTL subregions, namely, the anterior and posterior hippocampus (aHPC/pHPC), entorhinal cortex (ERC), Brodmann areas (BA) 35 and 36 [as perirhinal cortex (PRC) substructures], and parahippocampal cortex (PHC), were segmented from a T1-weighted MRI using a new longitudinal pipeline (LASHiS). Statistical analyses were performed using mixed models. Adult lifespan models highlighted both linear (PRC, BA35, BA36, PHC) and nonlinear (HPC, aHPC, pHPC, ERC) trajectories. Group comparisons showed reduced baseline volumes and steeper volume declines over time for most of the MTL subregions in Aβ+ MCI and AD patients compared to Aβ− CU, but no differences between Aβ− and Aβ+ CU or between Aβ+ MCI and AD patients (except in ERC). Over time, MCI-to-AD converters exhibited a greater volume decline than non-converters in HPC, aHPC, and pHPC. Most of the MTL subregions were related to episodic memory performances but not to executive functioning or speed processing. Overall, these results emphasize the benefits of studying MTL subregions to distinguish age-related changes from AD. Interestingly, MTL subregions are unequally vulnerable to aging, and those displaying non-linear age-trajectories, while not damaged in preclinical AD (Aβ+ CU), were particularly affected from the prodromal stage (Aβ+ MCI). This volume decline in hippocampal substructures might also provide information regarding the conversion from MCI to AD-dementia. All together, these findings provide new insights into MTL alterations, which are crucial for AD-biomarkers definition.
first_indexed 2024-12-16T08:34:16Z
format Article
id doaj.art-352465536b4447bcb5e26fe57d87f59b
institution Directory Open Access Journal
issn 1663-4365
language English
last_indexed 2024-12-16T08:34:16Z
publishDate 2021-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Aging Neuroscience
spelling doaj.art-352465536b4447bcb5e26fe57d87f59b2022-12-21T22:37:48ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652021-10-011310.3389/fnagi.2021.750154750154Medial Temporal Lobe Subregional Atrophy in Aging and Alzheimer's Disease: A Longitudinal StudyLéa Chauveau0Elizabeth Kuhn1Cassandre Palix2Francesca Felisatti3Valentin Ourry4Valentin Ourry5Vincent de La Sayette6Gaël Chételat7Robin de Flores8U1237 PhIND, Inserm, Caen-Normandie University, GIP Cyceron, Caen, FranceU1237 PhIND, Inserm, Caen-Normandie University, GIP Cyceron, Caen, FranceU1237 PhIND, Inserm, Caen-Normandie University, GIP Cyceron, Caen, FranceU1237 PhIND, Inserm, Caen-Normandie University, GIP Cyceron, Caen, FranceU1237 PhIND, Inserm, Caen-Normandie University, GIP Cyceron, Caen, FranceU1077 NIMH, Inserm, Caen-Normandie University, École Pratique des Hautes Études, Caen, FranceU1077 NIMH, Inserm, Caen-Normandie University, École Pratique des Hautes Études, Caen, FranceU1237 PhIND, Inserm, Caen-Normandie University, GIP Cyceron, Caen, FranceU1237 PhIND, Inserm, Caen-Normandie University, GIP Cyceron, Caen, FranceMedial temporal lobe (MTL) atrophy is a key feature of Alzheimer's disease (AD), however, it also occurs in typical aging. To enhance the clinical utility of this biomarker, we need to better understand the differential effects of age and AD by encompassing the full AD-continuum from cognitively unimpaired (CU) to dementia, including all MTL subregions with up-to-date approaches and using longitudinal designs to assess atrophy more sensitively. Age-related trajectories were estimated using the best-fitted polynomials in 209 CU adults (aged 19–85). Changes related to AD were investigated among amyloid-negative (Aβ−) (n = 46) and amyloid-positive (Aβ+) (n = 14) CU, Aβ+ patients with mild cognitive impairment (MCI) (n = 33) and AD (n = 31). Nineteen MCI-to-AD converters were also compared with 34 non-converters. Relationships with cognitive functioning were evaluated in 63 Aβ+ MCI and AD patients. All participants were followed up to 47 months. MTL subregions, namely, the anterior and posterior hippocampus (aHPC/pHPC), entorhinal cortex (ERC), Brodmann areas (BA) 35 and 36 [as perirhinal cortex (PRC) substructures], and parahippocampal cortex (PHC), were segmented from a T1-weighted MRI using a new longitudinal pipeline (LASHiS). Statistical analyses were performed using mixed models. Adult lifespan models highlighted both linear (PRC, BA35, BA36, PHC) and nonlinear (HPC, aHPC, pHPC, ERC) trajectories. Group comparisons showed reduced baseline volumes and steeper volume declines over time for most of the MTL subregions in Aβ+ MCI and AD patients compared to Aβ− CU, but no differences between Aβ− and Aβ+ CU or between Aβ+ MCI and AD patients (except in ERC). Over time, MCI-to-AD converters exhibited a greater volume decline than non-converters in HPC, aHPC, and pHPC. Most of the MTL subregions were related to episodic memory performances but not to executive functioning or speed processing. Overall, these results emphasize the benefits of studying MTL subregions to distinguish age-related changes from AD. Interestingly, MTL subregions are unequally vulnerable to aging, and those displaying non-linear age-trajectories, while not damaged in preclinical AD (Aβ+ CU), were particularly affected from the prodromal stage (Aβ+ MCI). This volume decline in hippocampal substructures might also provide information regarding the conversion from MCI to AD-dementia. All together, these findings provide new insights into MTL alterations, which are crucial for AD-biomarkers definition.https://www.frontiersin.org/articles/10.3389/fnagi.2021.750154/fullmedial temporal lobe (MTL)Alzheimer's diseaseagingepisodic memorystructural magnetic resonance imagingmild cognitive impairment
spellingShingle Léa Chauveau
Elizabeth Kuhn
Cassandre Palix
Francesca Felisatti
Valentin Ourry
Valentin Ourry
Vincent de La Sayette
Gaël Chételat
Robin de Flores
Medial Temporal Lobe Subregional Atrophy in Aging and Alzheimer's Disease: A Longitudinal Study
Frontiers in Aging Neuroscience
medial temporal lobe (MTL)
Alzheimer's disease
aging
episodic memory
structural magnetic resonance imaging
mild cognitive impairment
title Medial Temporal Lobe Subregional Atrophy in Aging and Alzheimer's Disease: A Longitudinal Study
title_full Medial Temporal Lobe Subregional Atrophy in Aging and Alzheimer's Disease: A Longitudinal Study
title_fullStr Medial Temporal Lobe Subregional Atrophy in Aging and Alzheimer's Disease: A Longitudinal Study
title_full_unstemmed Medial Temporal Lobe Subregional Atrophy in Aging and Alzheimer's Disease: A Longitudinal Study
title_short Medial Temporal Lobe Subregional Atrophy in Aging and Alzheimer's Disease: A Longitudinal Study
title_sort medial temporal lobe subregional atrophy in aging and alzheimer s disease a longitudinal study
topic medial temporal lobe (MTL)
Alzheimer's disease
aging
episodic memory
structural magnetic resonance imaging
mild cognitive impairment
url https://www.frontiersin.org/articles/10.3389/fnagi.2021.750154/full
work_keys_str_mv AT leachauveau medialtemporallobesubregionalatrophyinagingandalzheimersdiseasealongitudinalstudy
AT elizabethkuhn medialtemporallobesubregionalatrophyinagingandalzheimersdiseasealongitudinalstudy
AT cassandrepalix medialtemporallobesubregionalatrophyinagingandalzheimersdiseasealongitudinalstudy
AT francescafelisatti medialtemporallobesubregionalatrophyinagingandalzheimersdiseasealongitudinalstudy
AT valentinourry medialtemporallobesubregionalatrophyinagingandalzheimersdiseasealongitudinalstudy
AT valentinourry medialtemporallobesubregionalatrophyinagingandalzheimersdiseasealongitudinalstudy
AT vincentdelasayette medialtemporallobesubregionalatrophyinagingandalzheimersdiseasealongitudinalstudy
AT gaelchetelat medialtemporallobesubregionalatrophyinagingandalzheimersdiseasealongitudinalstudy
AT robindeflores medialtemporallobesubregionalatrophyinagingandalzheimersdiseasealongitudinalstudy